TOG Review (RCOG Journal)

MRCOG Part 2

Maternal Medicine

Skin eruptions specific to pregnancy – an overview

Key Statistics

  • 4 — Dermatoses unique to pregnancy
  • 1 in 300 — Atopic eruption – Commonest
  • 15 mg/kg/day — Ursodeoxycholic acid (ICP)

Don't-miss facts

  1. PEP = striae with periumbilical sparing, spares face/palms/soles · PG = starts around umbilicus, involves palms/soles, spares mucosa

  2. ICP: itch first (worst at night, hands/feet), rash is secondary to scratching — no primary lesion

  3. ICP treatment: UDCA 15 mg/kg/day (unlicensed in pregnancy – consent) + emollients + sedating antihistamines; discuss water-soluble vitamin K

  4. ICP: no cut-off for delivery, no reliable surveillance, induction not routine; repeat LFTs after 10 days postnatally

  5. PG: 2 perilesional biopsies (histology + DIF). DIF = C3 at basement membrane; IIF = IgG vs BP180. HLA-DR3/DR4. Check TFTs (Graves’)

  6. PG: prednisolone 30–40 mg (0.5 mg/kg), wean 5 mg every 3 days; 75% flare at delivery; monthly growth scans if IUGR suspected

  7. PEP first line = topical steroids; no maternal/fetal risk; do not induce; rarely recurs

  8. Refer to obstetric consultant: PG, ICP. Refer to dermatologist: PG, failed first-line PEP/AEP, or eruption with systemic symptoms

Fetal risk at a glance

No fetal risk: AEP · PEP Fetal risk: ICP (stillbirth, preterm, meconium, PPH) · PG (IUGR, ?preterm, neonatal lesions 1:10)

Incidence

AEP 1:300 PEP 1:160–1:300 PG 1:1700–1:50 000 ICP 0.7% (1.2–1.5% S. Asian)

Abbreviation Key

  • AEP — atopic eruption of pregnancy
  • UDCA — ursodeoxycholic acid
  • PEP — polymorphic eruption of pregnancy
  • DIF / IIF — direct / indirect immunofluorescence
  • PG — pemphigoid gestationis
  • BP180 — bullous pemphigoid antigen 2
  • ICP — intrahepatic cholestasis of pregnancy (obstetric cholestasis)
  • MSH — melanocyte-stimulating hormone
  • IUGR — intrauterine growth restriction
  • BAD — British Association of Dermatologists

Source: Maharajan A, Aye C, Ratnavel R, Burova E. Skin eruptions specific to pregnancy: an overview. The Obstetrician & Gynaecologist 2013;15:233–240. doi:10.1111/tog.12051

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free